Revolution in Neutralizing the Effects of Radiation Exposure

Radiation sickness develops with prolonged exposure to radiation. Until recently, the main problem was that it was impossible to cure – doctors could only prescribe supportive therapy aimed at preventing complications. But now everything has changed thanks to the development of the drug PLX-R18.

The Essence of the Problem

Radiation exposure can alter the DNA of cells, leading to their death (apoptosis). The bone marrow is primarily affected by ionizing radiation, resulting in disrupted production of new blood cells. Consequently, there is a deficiency of red blood cells (leading to anemia), platelets (which can cause bleeding), and white blood cells (resulting in infectious complications). This is the reason for the high mortality rate from radiation sickness.

Among the severe consequences of radiation exposure are dysfunction of the digestive system, damage to mucous membranes and skin, and disturbances in the central nervous system, which can lead to swelling and hemorrhages in the brain.

Innovative Solution

The drug PLX-R18, developed by Israeli scientists, has successfully passed trials on animals. It is still too early to talk about its effectiveness in humans, as conducting research involving radiation exposure to humans is prohibited in Israel. However, the data obtained during the experiments is very promising. The use of PLX-R18 in animals led to a significant reduction in mortality rates.

This revolutionary drug is made from cells harvested from the human placenta. Its active ingredient addresses the main problem that arises from radiation exposure – the disruption of hematopoietic function. PLX-R18 is administered intramuscularly within 4 days after radiation exposure and supports normal bone marrow function. Thus, the production of new blood cells is preserved.

Promising Prospects

The Israeli Ministry of Health is in dialogue with representatives of Pluristem to obtain permission to use the drug PLX-R18 in military medical units.

It is quite possible that over time and with further research, the use of nuclear weapons and technological disasters will not seem as daunting.